isirv

The Respiratory Syncytial Virus (RSV) Society is holding their 11th International RSV Symposium at the Omni Grove Park Inn Asheville, North Carolina.This is the premier global conference for RSV researchers in academia and industry, hosting scientists, students, non-profits, regulators, sponsors and industry. Further details can be found on the website.   Register here 

This conference will address both pre-clinical and clinical advances in therapeutic and prophylactic agents for influenza, RSV and other respiratory viruses and regulatory issues central to advancing such agents to clinical practice. Visit the website

Late-breaking abstracts accepted to 31 October Registration is OPEN

The next Epidemiology Group conference is planned to take place at the new ECDC facilities in Stockholm. This is an interdisciplinary meeting bringing together epidemiologists, clinical researchers, as well as experts in public health, risk analysis, big data and global health. The focus will be on severe disease presentations with influenza and other respiratory viral infections. Further details will be available shortly on the website.

This conference will address new immunological assays and immune correlates of protection needed to estimate the immunogenicity and protective efficacy of next generation influenza vaccines currently being developed. Website

Planning is well underway for the 10th edition of the Options for the Control of Influenza conference in Singapore. This is ISIRV's premier event and remains the largest international conference exclusively dedicated to influenza prevention, control and treatment, including seasonal flu and pandemic preparedness. Highlights of the meeting include: new tracks on influenza co-infections with other viral pathogens and key issues for policy making - new Chinese-speaking track (Mandarin) with dual-translation to showcase the latest developments in Chinese-speaking countries - pre-conference workshops on a wide variety of topics including  technology, mathematical modelling and bioinformatics. Watch this space - the website will open shortly.  Flyer here

Anti-Flu drug approved for treatment of influenza types A and B in Japan - press release here.

The recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season can be found here.

The update 'Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness' is here.

Information and links to other sources of information on this evolving situation is available in the news section.

In mid-2017, the International Respiratory Syncytial Virus Society (IRSVS) became a special interest group of isirv. The IRSVS is a global independent group of RSV professionals, with members from all continents working on all research fronts. The IRSVS’s goal is to ensure that there is a succession of venues to share scientific information and accelerate the development of strategies to reduce the impact of RSV infection.

Read more...

Highlights from Influenza 2018: Centenary of the 1918 Pandemic | 24-26 June at the Crick Institute, London

The greatest public health disaster in recorded history, the Spanish Flu, began in springtime of 1918 and developed within a few months into a global pandemic with an estimated 50-100 million deaths. By its end, the pandemic had caused a reduction of life expectancy in the US by 12 years, and killed more people than died in the First World War. Read more...